Missouri 2025 Regular Session

Missouri Senate Bill SB299 Latest Draft

Bill / Introduced Version Filed 12/10/2024

                             
EXPLANATION-Matter enclosed in bold-faced brackets [thus] in this bill is not enacted 
and is intended to be omitted in the law. 
FIRST REGULAR SESSION 
SENATE BILL NO. 299 
103RD GENERAL ASSEMBLY  
INTRODUCED BY SENATOR MOON. 
1061S.01I 	KRISTINA MARTIN, Secretary  
AN ACT 
To repeal sections 354.535 and 376.386, RSMo, and to enact in lieu thereof two new sections 
relating to cost-sharing for prescription drugs. 
 
Be it enacted by the General Assembly of the State of Missouri, as follows: 
     Section A. Sections 354.535 and 376.386, RSMo, are 1 
repealed and two new sections enacted in lieu thereof, to be 2 
known as sections 354.535 and 376.386, to read as follows:3 
     354.535.  1.  If a pharmacy, operated by or contracted 1 
with by a health maintenance organization, is closed or is 2 
unable to provide health care services to an enrollee in an 3 
emergency, a pharmacist may take an assignment of suc h  4 
enrollee's right to reimbursement, if the policy or contract 5 
provides for such reimbursement, for those goods or services 6 
provided to an enrollee of a health maintenance 7 
organization.  No health maintenance organization shall 8 
refuse to pay the pharm acist any payment due the enrollee 9 
under the terms of the policy or contract. 10 
     2.  No health maintenance organization, conducting 11 
business in the state of Missouri, shall contract with a 12 
pharmacy, pharmacy distributor or wholesale drug 13 
distributor, nonresident or otherwise, unless such pharmacy 14 
or distributor has been granted a permit or license from the 15 
Missouri board of pharmacy to operate in this state. 16 
     3.  Every health maintenance organization shall apply 17 
the same coinsurance, co -payment and deductible factors to 18   SB 299 	2 
all drug prescriptions filled by a pharmacy provider who 19 
participates in the health maintenance organization's 20 
network if the provider meets the contract's explicit 21 
product cost determination.  If any such contract is 22 
rejected by any pharmacy provider, the health maintenance 23 
organization may offer other contracts necessary to comply 24 
with any network adequacy provisions of this act.  However,  25 
nothing in this section shall be construed to prohibit the 26 
health maintenance org anization from applying different 27 
coinsurance, co-payment and deductible factors between 28 
generic and brand name drugs. 29 
     4.  If the cost-sharing applied by a health maintenance 30 
organization exceeds the usual and customary retail price of 31 
the prescription drug, enrollees shall only be required to 32 
pay the usual and customary retail price of the prescription 33 
drug, and no further charge to the enrollee or plan sponsor 34 
shall be incurred on such prescription. 35 
     5.  Health maintenance organizations sh all not set a  36 
limit on the quantity of drugs which an enrollee may obtain 37 
at any one time with a prescription, unless such limit is 38 
applied uniformly to all pharmacy providers in the health 39 
maintenance organization's network. 40 
     [5.] 6.  Health maintenance organizations shall not 41 
insist or mandate any physician or other licensed health 42 
care practitioner to change an enrollee's maintenance drug 43 
unless the provider and enrollee agree to such change.  For  44 
the purposes of this provision, a maintenance drug shall  45 
mean a drug prescribed by a practitioner who is licensed to 46 
prescribe drugs, used to treat a medical condition for a 47 
period greater than thirty days.  Violations of this 48 
provision shall be subject to the penalties provided in 49 
section 354.444.  Notwithstanding other provisions of law to 50   SB 299 	3 
the contrary, health maintenance organizations that change 51 
an enrollee's maintenance drug without the consent of the 52 
provider and enrollee shall be liable for any damages 53 
resulting from such change.  Nothing in this subsection, 54 
however, shall apply to the dispensing of generically 55 
equivalent products for prescribed brand name maintenance 56 
drugs as set forth in section 338.056. 57 
     376.386.  1.  For any health carrier or health benefit 1 
plan, as defined in section 376.1350, that provides 2 
prescription drug coverage, if a prescription drug covered 3 
by a health carrier or health benefit plan is prescribed in 4 
a single dosage amount for which the particular prescription 5 
drug is not manufacture d in such single dosage amount and 6 
requires dispensing the particular prescription drug in a 7 
combination of different manufactured dosage amounts, the 8 
health carrier or health benefit plan shall only impose one 9 
co-payment for the dispensing of the comb ination of  10 
manufactured dosages that equal the prescribed dosage for 11 
such prescription drug.  Such co-payment requirement shall 12 
not apply to prescriptions in excess of a one -month supply.   13 
If technology does not permit such adjudication, the health 14 
carrier or health benefit plan shall provide reimbursement 15 
forms for the patient. 16 
     2.  If the cost-sharing for prescription drugs applied 17 
by a health carrier, as defined in section 376.1350, exceeds 18 
the usual and customary retail price of the prescrip tion  19 
drug, enrollees shall only be required to pay the usual and 20 
customary retail price of the prescription drug, and no 21 
further charge to the enrollee or plan sponsor shall be 22 
incurred on such prescription. 23 
